Alnylam Pharma slips after big rally

Morgan Stanley cuts Alnylam Pharmaceuticals (ALNY -4.6%) to Equalweight from Overweight.

The shares are lower in early trading on the heels of Monday's big rally.

See also: ALNY and Sanofi deepen relationship

Also: ALNY acquires MRK unit

From other sites
Comments (2)
  • Anonymous 2
    , contributor
    Comments (369) | Send Message
    it might be "of interest" to readers if one or more of your Technical analyst gurus can shed any light on the "coincidence of stocks" which "tend to fill the Gaps" (almost always) left between the close on one day and the opening price on the next day.
    In this case there is a 20 point gap.
    It might also be of interest to your readers to learn about the difference between the use of


    (A) the pattern of positive or negative change in the closing price between two days
    (B) The pattern of positive or negative changes between the opening price and the closing price


    ... to determine market Accumulation vs Distribution assuming the specialist is in a position to know more about what is in the crowd at his post and what is in his book which enables him to
    operate at a profit (this is why he is business) while maintaining an orderly market.
    14 Jan 2014, 12:17 PM Reply Like
  • Crash survivor87
    , contributor
    Comments (213) | Send Message
    MS has, had and won't have a clue what's happening at ALNY.
    Their spreadsheets don't work with this kind of companies.
    Holders of Biomarin and Alexion know what I mean.
    14 Jan 2014, 01:01 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs